Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Rapamune in Indian Renal Transplant Patients
NCT00195481Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 2004
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sirolimus in kidney transplant rejection, sponsored by Pfizer. Primary endpoint: Safety evaluation. Started Apr 2004; status: completed.
02
Drugs
sirolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT00195481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00195481.